
Sign up to save your podcasts
Or
Summary
“Understanding how a device operates in the clinical environment is critical for managing patient safety risks, especially for diagnostic devices.”
In this Let’s Talk Risk! conversation, Naveen Agarwal engages with Dr. Marc Rubinstein, head of medical safety at GRAIL, discussing the critical aspects of medical safety and risk management in the medical device industry. They explore Dr. Rubinstein's transition from clinical practice to the industry, the importance of integrating medical safety early in product development, and the challenges faced in managing risks associated with diagnostic devices. The conversation also highlights the significance of post-market surveillance, the relationship between cybersecurity and patient safety, and the necessity of cross-functional collaboration to ensure patient-centered outcomes.
Listen to the full 30-minute podcast or jump to a section of interest listed below.
Chapters
00:10 Introducing Dr. Marc Rubinstein
01:50 Integrating Medical Safety Early in Development
03:09 Challenges in Risk Management for Diagnostics
05:41 Collaborating with Medical Safety for Risk Analysis
09:15 Post-Market Surveillance and Learning from Real World Data
13:10 Leveraging Post-Market Experience for New Innovations
16:33 Linking Cybersecurity and Patient Safety
18:30 Best Practices for Post-Market Feedback for New Products
24:00 Key Takeaways and Closing Comments
If you enjoyed this podcast, consider subscribing to the Let’s Talk Risk! newsletter.
Suggested links:
LTR: Critical role of medical safety officer in medical devices.
LTR: Tips for clinicians transitioning into medical safety role.
LTR: Tips for improving collaboration in risk management.
ACHIEVE: Post-market surveillance workshop.
Key Takeaways
* Integrating medical safety early in product development is crucial for patient safety.
* Risk management in diagnostics involves understanding complex relationships between devices and patient outcomes.
* Post-market surveillance is essential for learning from real-world use and improving products.
* Cybersecurity risks must be considered even for non-life-sustaining devices.
* Cross-functional collaboration is key to effective risk management and patient safety.
* Education and training for users of medical devices are vital to prevent misuse.
* Understanding the severity and probability of risks is essential for accurate risk assessment.
* Feedback loops from post-market data can inform future product development.
* Patient safety should always be at the center of decision-making in medical device development.
Keywords
Medical safety, risk management, diagnostics, post-market surveillance, cybersecurity, cross-functional collaboration, patient safety, medical devices, healthcare industry, clinician insights
About Marc Rubinstein, MD, MBA
Marc Rubinstein is the head of Medical Safety at GRAIL where he is responsible for developing and implementing a robust medical safety program across the total product lifecycle. In a career spanning more than 10 years, he has held leadership roles at several MedTech companies including Baxter and Philips. Dr. Rubinstein is known as a collaborative executive, leading with a strong passion for patient safety, while also achieving full compliance with applicable regulatory requirements. He holds an MD with General Surgery residency at University of Southern California, and an MBA from University of Tennessee.
Let’s Talk Risk! with Dr. Naveen Agarwal is a weekly live audio event on LinkedIn, where we talk about risk management related topics in a casual, informal way. Join us at 11:00 am EST every Friday on LinkedIn.
Disclaimer
Information and insights presented in this podcast are for educational purposes only, and not as legal advice. Views expressed by all speakers are their own and do not reflect those of their respective organizations.
Parts of this article were created using AI-generated content, which was subsequently reviewed, edited, and fact-checked by the author to ensure accuracy and alignment with our standards.
5
22 ratings
Summary
“Understanding how a device operates in the clinical environment is critical for managing patient safety risks, especially for diagnostic devices.”
In this Let’s Talk Risk! conversation, Naveen Agarwal engages with Dr. Marc Rubinstein, head of medical safety at GRAIL, discussing the critical aspects of medical safety and risk management in the medical device industry. They explore Dr. Rubinstein's transition from clinical practice to the industry, the importance of integrating medical safety early in product development, and the challenges faced in managing risks associated with diagnostic devices. The conversation also highlights the significance of post-market surveillance, the relationship between cybersecurity and patient safety, and the necessity of cross-functional collaboration to ensure patient-centered outcomes.
Listen to the full 30-minute podcast or jump to a section of interest listed below.
Chapters
00:10 Introducing Dr. Marc Rubinstein
01:50 Integrating Medical Safety Early in Development
03:09 Challenges in Risk Management for Diagnostics
05:41 Collaborating with Medical Safety for Risk Analysis
09:15 Post-Market Surveillance and Learning from Real World Data
13:10 Leveraging Post-Market Experience for New Innovations
16:33 Linking Cybersecurity and Patient Safety
18:30 Best Practices for Post-Market Feedback for New Products
24:00 Key Takeaways and Closing Comments
If you enjoyed this podcast, consider subscribing to the Let’s Talk Risk! newsletter.
Suggested links:
LTR: Critical role of medical safety officer in medical devices.
LTR: Tips for clinicians transitioning into medical safety role.
LTR: Tips for improving collaboration in risk management.
ACHIEVE: Post-market surveillance workshop.
Key Takeaways
* Integrating medical safety early in product development is crucial for patient safety.
* Risk management in diagnostics involves understanding complex relationships between devices and patient outcomes.
* Post-market surveillance is essential for learning from real-world use and improving products.
* Cybersecurity risks must be considered even for non-life-sustaining devices.
* Cross-functional collaboration is key to effective risk management and patient safety.
* Education and training for users of medical devices are vital to prevent misuse.
* Understanding the severity and probability of risks is essential for accurate risk assessment.
* Feedback loops from post-market data can inform future product development.
* Patient safety should always be at the center of decision-making in medical device development.
Keywords
Medical safety, risk management, diagnostics, post-market surveillance, cybersecurity, cross-functional collaboration, patient safety, medical devices, healthcare industry, clinician insights
About Marc Rubinstein, MD, MBA
Marc Rubinstein is the head of Medical Safety at GRAIL where he is responsible for developing and implementing a robust medical safety program across the total product lifecycle. In a career spanning more than 10 years, he has held leadership roles at several MedTech companies including Baxter and Philips. Dr. Rubinstein is known as a collaborative executive, leading with a strong passion for patient safety, while also achieving full compliance with applicable regulatory requirements. He holds an MD with General Surgery residency at University of Southern California, and an MBA from University of Tennessee.
Let’s Talk Risk! with Dr. Naveen Agarwal is a weekly live audio event on LinkedIn, where we talk about risk management related topics in a casual, informal way. Join us at 11:00 am EST every Friday on LinkedIn.
Disclaimer
Information and insights presented in this podcast are for educational purposes only, and not as legal advice. Views expressed by all speakers are their own and do not reflect those of their respective organizations.
Parts of this article were created using AI-generated content, which was subsequently reviewed, edited, and fact-checked by the author to ensure accuracy and alignment with our standards.
14,376 Listeners